1.
Ann Intern Med
; 172(11): 754-755, 2020 06 02.
Article
in English
| MEDLINE | ID: covidwho-2144990
Subject(s)
Chloroquine/therapeutic use , Coronavirus Infections/drug therapy , Hydroxychloroquine/therapeutic use , Pneumonia, Viral/drug therapy , Rheumatic Diseases/drug therapy , Betacoronavirus , COVID-19 , Chloroquine/supply & distribution , Drug Repositioning , Humans , Hydroxychloroquine/supply & distribution , Pandemics , Randomized Controlled Trials as Topic , SARS-CoV-2 , COVID-19 Drug Treatment
2.
Clin Rheumatol
; 39(7): 2039-2042, 2020 07.
Article
in English
| MEDLINE | ID: covidwho-980847
Subject(s)
Coronavirus Infections/epidemiology , Delivery of Health Care/methods , Developing Countries , Pneumonia, Viral/epidemiology , Antirheumatic Agents/adverse effects , Antirheumatic Agents/supply & distribution , Betacoronavirus , COVID-19 , Chloroquine/supply & distribution , Coronavirus Infections/immunology , Humans , Hydroxychloroquine/supply & distribution , Immunocompromised Host , Pandemics , Pneumonia, Viral/immunology , Rheumatic Diseases/drug therapy , Rheumatic Diseases/immunology , SARS-CoV-2 , Telemedicine
3.
Lancet Infect Dis
; 20(10): 1118-1119, 2020 10.
Article
in English
| MEDLINE | ID: covidwho-72034
Subject(s)
Coronavirus Infections/prevention & control , Hydroxychloroquine/therapeutic use , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Pre-Exposure Prophylaxis , Betacoronavirus , COVID-19 , Chloroquine/supply & distribution , Chloroquine/therapeutic use , Contact Tracing , Coronavirus Infections/drug therapy , Family Characteristics , Humans , Hydroxychloroquine/supply & distribution , India , SARS-CoV-2 , COVID-19 Drug Treatment
4.
N Engl J Med
; 382(24): 2282-2284, 2020 Jun 11.
Article
in English
| MEDLINE | ID: covidwho-61913
Subject(s)
Coronavirus Infections/drug therapy , Drug Approval , Drug Evaluation/standards , Pneumonia, Viral/drug therapy , Betacoronavirus , COVID-19 , Chloroquine/supply & distribution , Chloroquine/therapeutic use , Clinical Trials as Topic , Drugs, Investigational/therapeutic use , Humans , Hydroxychloroquine/supply & distribution , Hydroxychloroquine/therapeutic use , Off-Label Use , Pandemics , SARS-CoV-2 , United States , United States Food and Drug Administration , COVID-19 Drug Treatment
5.
Lancet
; 395(10231): 1179, 2020 04 11.
Article
in English
| MEDLINE | ID: covidwho-47145
Subject(s)
Antimalarials/adverse effects , Chloroquine/adverse effects , Coronavirus Infections/drug therapy , Drug Approval/legislation & jurisprudence , Hydroxychloroquine/adverse effects , Pneumonia, Viral/drug therapy , Antimalarials/supply & distribution , Antimalarials/therapeutic use , Betacoronavirus , COVID-19 , Chloroquine/supply & distribution , Chloroquine/therapeutic use , Coronavirus Infections/epidemiology , Drug Approval/organization & administration , European Union , Humans , Hydroxychloroquine/supply & distribution , Hydroxychloroquine/therapeutic use , Pandemics/legislation & jurisprudence , Pneumonia, Viral/epidemiology , SARS-CoV-2 , United States/epidemiology
6.
Nat Med
; 26(5): 632, 2020 05.
Article
in English
| MEDLINE | ID: covidwho-47143
Subject(s)
Betacoronavirus , Chloroquine/therapeutic use , Coronavirus Infections/drug therapy , Hydroxychloroquine/therapeutic use , Lupus Erythematosus, Systemic , Pneumonia, Viral/drug therapy , COVID-19 , Chloroquine/supply & distribution , Fear , Humans , Hydroxychloroquine/supply & distribution , Lupus Erythematosus, Systemic/drug therapy , Pandemics , SARS-CoV-2 , COVID-19 Drug Treatment
7.
Med Mal Infect
; 50(3): 229-230, 2020 05.
Article
in English
| MEDLINE | ID: covidwho-27342